Texas Execution Plan Tested by Tennessee Failure and Drug Questions
Texas was scheduled to execute Jamaal Howard by lethal injection on Wednesday, 7 October 2026. It would have been the first execution in the United States since the botched lethal injection of Christa Pike in Tennessee the prior week. Howard's lawyers sought to halt it, arguing similar risks applied The Guardian.
Howard was 46. He was found guilty of capital murder in 2001, the Texas charge for murder with specific aggravating factors, for the 2000 killing of 42-year-old clerk Vickie Swartout during a robbery of a convenience store in Silsbee, Texas The Guardian. Prison records state he shot Swartout one time in the chest, causing her death, and took $114 from the cash register Texas Department of Criminal Justice. His state inmate number is 999383 Texas Department of Criminal Justice.
Two distinct legal challenges framed the final days. First, Howard's legal team argued he was intellectually disabled at the time of the crime, meaning significant limits in intellectual functioning and daily skills, and thus ineligible for the death penalty. The U.S. Supreme Court ruled in 2002 that intellectually disabled people are ineligible for execution. That claim did not stop the schedule from advancing. The Fifth Circuit Court of Appeals, the federal appeals court covering Texas, declined a request last week to stop Howard's execution. A Texas court denied a stay request, a formal order to pause, on Wednesday.
The second challenge concerned method. Texas officials planned to administer pentobarbital, the same barbiturate sedative used in Pike's case The Guardian. It is a drug that slows brain activity to cause sedation and death at high doses. Howard's attorneys filed requests for information about the lethal dose the Texas Department of Criminal Justice planned to use. They also filed a Wednesday motion with Texas's Court of Criminal Appeals, the state's highest criminal court, arguing the state's execution drugs may be degraded past beyond-use dates, the cutoff dates after which a drug may lose strength or safety. A Texas attorney general opinion on releasing execution-drug information was not expected until after Wednesday.
Pike's case supplied the factual basis for that drug challenge. Tennessee carried out its 30 September 2026 execution attempt of Pike, inmate number 261368, at the Riverbend Maximum Security Institution Tennessee Department of Correction. Pike survived two doses of pentobarbital. As the drug was given, she said her arms felt like they were going to explode. She regained consciousness on Tuesday after the botched execution. Her lawyers said she has pneumonia and is unable to move her arms.
Pike's lawyers had previously argued her blood disorder would make a lethal injection painful. Her case was the second botched execution in Tennessee this year. In response, Tennessee Governor Bill Lee barred any further lethal injections for the rest of the year and ordered a probe into why Pike's execution failed.
Pike remains the only woman serving a sentence on Tennessee's death row Tennessee Department of Correction. She was convicted of first-degree murder in 1996 and sentenced to death that year for first-degree murder in Knox County.
The broader context here is a collision between protocol secrecy and judicial willingness to proceed. Texas was moving forward while disclosure about drug potency and sourcing remained pending past the execution date, and while Tennessee had paused its own program to examine an almost identical drug failure. For practitioners, the questions to watch are narrow and technical. Whether courts treat a recent out-of-state botched execution with the same drug as evidence of unreasonable risk, how beyond-use-date claims are adjudicated without pre-execution disclosure, and how intellectual-disability claims dating to convictions entered before the 2002 prohibition are evaluated in successive petitions. The answers will shape the next warrants as much as this one.
